Roberto Pecoits‐Filho

Research interests

Publications

• Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

  Kidney International · 2021 · https://doi.org/10.1016/j.kint.2021.03.020

• A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

  Kidney International · 2021 · 10.1016/j.kint.2021.03.033

• KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

  Kidney International · 2021 · https://doi.org/10.1016/j.kint.2020.11.003

• Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease

  Kidney International · 2021 · https://doi.org/10.1016/j.kint.2020.10.026

• Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Kidney International · 2020 · https://doi.org/10.1016/j.kint.2020.01.046

• Establishing a Core Outcome Set for Peritoneal Dialysis: Report of the SONG-PD (Standardized Outcomes in Nephrology–Peritoneal Dialysis) Consensus Workshop

  American Journal of Kidney Diseases · 2020 · https://doi.org/10.1053/j.ajkd.2019.09.017

• Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Kidney International · 2019 · https://doi.org/10.1016/j.kint.2019.06.025

• Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(19)30772-x

• Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Kidney International · 2019 · https://doi.org/10.1016/j.kint.2019.09.018

• Chronic Kidney Disease and Coronary Artery Disease

  Journal of the American College of Cardiology · 2019 · https://doi.org/10.1016/j.jacc.2019.08.1017

• Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

  Nephrology Dialysis Transplantation · 2019 · https://doi.org/10.1093/ndt/gfz290

• Increasing access to integrated ESKD care as part of universal health coverage

  Kidney International · 2019 · https://doi.org/10.1016/j.kint.2018.12.005

• Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  Kidney International · 2019 · https://doi.org/10.1016/j.kint.2019.02.022

• Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

  European Heart Journal · 2018 · https://doi.org/10.1093/eurheartj/ehy060

• Occupational Heat Stress and Kidney Health: From Farms to Factories

  Kidney International Reports · 2017 · 10.1016/j.ekir.2017.08.012

• Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

  The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(17)30788-2

• Changes in the worldwide epidemiology of peritoneal dialysis

  Nature Reviews Nephrology · 2016 · 10.1038/nrneph.2016.181

• Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

  Kidney International · 2016 · 10.1016/j.kint.2015.10.002

• Peritoneal Dialysis for Acute Kidney Injury

  Peritoneal Dialysis International · 2014 · 10.3747/pdi.2013.00222

• Left Ventricular Mass in Chronic Kidney Disease and ESRD

  Clinical Journal of the American Society of Nephrology · 2009 · 10.2215/cjn.04860709

• Aspects of Immune Dysfunction in End-stage Renal Disease

  Clinical Journal of the American Society of Nephrology · 2008 · https://doi.org/10.2215/cjn.00950208

• IL-10, IL-6, and TNF-α: Central factors in the altered cytokine network of uremia—The good, the bad, and the ugly

  Kidney International · 2005 · https://doi.org/10.1111/j.1523-1755.2005.00200.x

• Serum Albumin, C-Reactive Protein, Interleukin 6, and Fetuin A as Predictors of Malnutrition, Cardiovascular Disease, and Mortality in Patients With ESRD

  American Journal of Kidney Diseases · 2005 · 10.1053/j.ajkd.2005.09.014

• Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin

  Kidney International · 2005 · 10.1111/j.1523-1755.2005.00345.x

• Associations between circulating inflammatory markers and residual renal function in CRF patients

  American Journal of Kidney Diseases · 2003 · 10.1016/s0272-6386(03)00353-6

• Coronary Artery Disease in End-Stage Renal Disease

  Journal of the American Society of Nephrology · 2003 · 10.1097/01.asn.0000069165.79509.42

• The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter

  Nephrology Dialysis Transplantation · 2002 · 10.1093/ndt/17.suppl_11.28

• Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment

  Nephrology Dialysis Transplantation · 2002 · 10.1093/ndt/17.9.1684

Current projects

No projects listed.